AB1894 amends Section 2300 of the California Fish and Game Code, which bans the sale, possession, importation, transportation, transfer, live release, and uncompensated giving away of salt water algae of the genus Caulerpa. The bill preserves the existing exception allowing possession for bona fide scientific research when the Department of Fish and Wildlife (DFW) determines and authorizes the work, and it retains the civil penalty range of $500 to $10,000 per violation.
On its face the measure is a set of non‑substantive language changes intended to restate the statutory prohibition and exception. Practical significance is limited: the underlying obligations, the department's gatekeeping role over research holdings, and the civil penalty framework remain in force.
That said, the introduced draft contains duplicated and awkward phrasing that could generate questions about how DFW and courts interpret authorization procedures, the scope of prohibited conduct, and how the per‑violation penalty is applied.
At a Glance
What It Does
AB1894 rewrites the language of Fish & Game Code §2300 without changing the core prohibitions: it continues to bar sale, possession, importation, transport, transfer, live release in California, and giving away without consideration of Caulerpa. The bill keeps the research exception conditioned on DFW determination and authorization and preserves the civil penalty range of $500–$10,000 per violation.
Who It Affects
The bill directly affects aquarium retailers, marine hobbyists, public aquaria, universities and research labs that handle marine algae, environmental nonprofit removal teams, and DFW enforcement and permitting staff. Compliance officers for businesses and research administrators should review internal policies against the statute's language.
Why It Matters
Because the statutory prohibition is strict, even technical redrafting can change how the rule is applied in permitting, enforcement, and litigation. Agencies and regulated parties should expect DFW to issue operational guidance; ambiguity in the draft could trigger additional administrative or judicial clarification.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
AB1894 targets Section 2300 of the Fish and Game Code, which treats salt water algae of the genus Caulerpa as an invasive organism subject to a broad prohibition. The bill leaves intact the long‑standing list of prohibited actions — selling, possessing, importing, transporting, transferring, releasing alive within California, and giving away without consideration — so regulated actors remain barred from both commercial and many noncommercial interactions with Caulerpa unless a narrow exception applies.
The statute retains a research exception: a person may possess Caulerpa for bona fide scientific research when the Department of Fish and Wildlife both determines that the activity qualifies and grants authorization. Practically, that means researchers should continue to expect DFW involvement before bringing or keeping specimens; nothing in this draft creates an automatic or de facto right to possess for study.
The bill does not set out a permitting process, timelines, application standards, or appeal procedures, so operational details stay with DFW's internal practices and any implementing regulations.AB1894 keeps the monetary deterrent in place: a civil penalty floor of $500 and ceiling of $10,000 for each violation. The text does not add criminal penalties, nor does it create new compliance programs, funding, or recordkeeping requirements.
Because the edits are presented as non‑substantive, the statute's practical compliance footprint for businesses and researchers remains essentially the same — but the bill's drafting quirks may shift where compliance risk materializes (for example, in discretionary authorizations or enforcement interpretations).
The Five Things You Need to Know
The bill leaves a comprehensive ban on Caulerpa intact: sale, possession, import, transport, transfer, live release within California, and giving away without consideration remain prohibited.
AB1894 preserves the research exception but ties it to DFW's determination and explicit authorization for bona fide scientific work.
The civil penalty provision stays unchanged in substance: each violation carries a civil fine between $500 and $10,000.
The legislative digest describes the edits as nonsubstantive language changes, not substantive policy shifts.
The bill text as introduced contains duplicated and awkward phrasing (e.g.
'No A person,' 'authorization by of, the department,' 'any a person') that could create interpretive or implementation questions.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Prohibition on sale, possession, importation, transport, transfer, live release, and uncompensated giveaway
This subsection restates the broad set of acts the statute forbids with respect to Caulerpa. For regulated parties, the practical effect is unchanged: commercial transactions and many forms of private handling are banned. Enforcement remains per‑act; because the provision lists a range of activities, compliance officers must map their operations (shipping, inventory, specimen handling, transfers) to the statutory verbs to assess risk.
Research possession allowed only with DFW determination and authorization
Subsection (b) keeps the long‑standing carve‑out for bona fide scientific research but makes possession conditional on the department both determining the research qualifies and authorizing possession. The language places gatekeeping authority squarely with DFW. The statute does not specify how authorization is documented, what standards constitute 'bona fide' research, or how quickly DFW must act — leaving those operational details to the department and potentially to future rulemaking or litigation.
Civil penalties retained and applied per violation
This subsection preserves the civil penalty range of $500 to $10,000 for each violation of the section. The per‑violation framing can multiply liability exposure depending on how an enforcement action defines a discrete violation (per specimen, per transaction, per day, etc.). The bill does not add criminal sanctions or new enforcement pathways; it supplements existing remedies but leaves procedural enforcement and burden‑of‑proof questions to current statutory schemes and agency practices.
This bill is one of many.
Codify tracks hundreds of bills on Environment across all five countries.
Explore Environment in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Native marine ecosystems and conservation groups — they keep the statutory prohibition that helps prevent establishment and spread of an invasive seaweed genus.
- Department of Fish and Wildlife — the statute preserves DFW's discretionary control over research authorizations and maintains civil enforcement tools.
- Academic and government researchers who study invasive algae — they retain an explicit statutory pathway to possess Caulerpa for research when authorized by DFW.
- Environmental NGOs and response contractors — they keep the legal basis to seek enforcement actions or participate in removal efforts under the existing ban.
Who Bears the Cost
- Aquarium retailers, hobbyists, and public aquaria — they continue to face a strict prohibition that limits transactions and specimen handling and exposes them to civil fines if they misstep.
- Small research institutions and campus labs — they must secure DFW authorization before holding specimens, adding administrative steps and potential delays to research projects.
- Department of Fish and Wildlife — DFW retains responsibility for reviewing research requests and enforcing the ban, which requires staff time and program resources despite no new funding in the bill.
- Courts and litigants — ambiguous or awkward drafting in the bill could produce disputes over interpretation (e.g., what counts as a single violation), increasing litigation and adjudication costs.
Key Issues
The Core Tension
The statute wrestles with a classic policy dilemma: a strict, prophylactic ban is a blunt but effective way to prevent ecological harm from a highly invasive species, but strict rules plus broad per‑violation fines can impose undue administrative and financial burdens on researchers, small institutions, and legitimate actors — and the bill's awkward drafting increases legal uncertainty rather than clarifying the balance.
On paper, AB1894 is a technical restatement of an existing prohibition. In practice, the measure raises two implementation questions.
First, the draft's duplicate and awkward phrases introduce potential ambiguities that could matter in close enforcement or permitting cases — courts and DFW may need to interpret whether apparent typographical errors were intended to change scope. Second, the statute leaves operational details to the department: it does not define 'bona fide' scientific research, require written permits with specified conditions, set timelines for DFW decisions, or explain how civil penalties are calculated when multiple specimens or transactions are involved.
Those gaps shift the burden to administrative practice and, if challenged, to judicial interpretation.
Another tension concerns proportionality. The per‑violation civil penalty can produce high aggregate exposure if DFW or a plaintiff characterizes each specimen, day, or transaction as a separate violation.
The bill does not add mitigating factors, alternative compliance pathways, or de minimis exceptions for inadvertent possession. That leaves businesses and researchers operating near the margin with compliance uncertainty and potential for disproportionate fines absent clear agency guidance or regulations.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.